EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent progress on gene-deleted live-attenuated African swine fever virus vaccines

Hiep L X Vu, D Scott McVey

npj Vaccines · 13.03.2024 · 9 (1)

DOI: 10.1038/s41541-024-00845-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift npj Vaccines, online erschienen am 13.03.2024. Verfasst von Hiep L X Vu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Science, and Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE, USA. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Agriculture | National Institute of Food and Agriculture (NIFA), United States Department of Agriculture | Agricultural Research Service (USDA Agricultural Research Service), University of Nebraska-Lincoln Agricultural Research Division.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

African Swine Fever (ASF) is a highly lethal viral disease in swine, with mortality rates approaching 100%. The disease has spread to many swine-producing countries, leading to significant economic losses and adversely impacting global food security. Extensive efforts have been directed toward developing effective ASF vaccines. Among the vaccinology approaches tested to date, live-attenuated virus (LAV) vaccines produced by rational deleting virulence genes from virulent African Swine Fever Virus (ASFV) strains have demonstrated promising safety and efficacy in experimental and field conditions. Many gene-deleted LAV vaccine candidates have been generated in recent years. The virulence genes targeted for deletion from the genome of virulent ASFV strains can be categorized into four groups: Genes implicated in viral genome replication and transcription, genes from the multigene family located at both 5′ and 3′ termini, genes participating in mediating hemadsorption and putative cellular attachment factors, and novel genes with no known functions. Some promising LAV vaccine candidates are generated by deleting a single viral virulence gene, whereas others are generated by simultaneously deleting multiple genes. This article summarizes the recent progress in developing and characterizing gene-deleted LAV vaccine candidates.

Autor:innen und Institutionen

  • Department of Animal Science, and Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE, USA.
  • School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE, USA. dmcvey2@unl.edu.

Förderung

  • United States Department of Agriculture | National Institute of Food and Agriculture (NIFA)
  • United States Department of Agriculture | Agricultural Research Service (USDA Agricultural Research Service)
  • University of Nebraska-Lincoln Agricultural Research Division

Zitieren

APA

Vu, H. L. X., & McVey, D. S. (2024). Recent progress on gene-deleted live-attenuated African swine fever virus vaccines. npj Vaccines, 9(1). https://doi.org/10.1038/s41541-024-00845-9

Vancouver

Vu HLX, McVey DS. Recent progress on gene-deleted live-attenuated African swine fever virus vaccines. npj Vaccines. 2024;9(1). doi:10.1038/s41541-024-00845-9

BibTeX
@article{Vu2024,
  author = {Vu, Hiep L X and McVey, D Scott},
  title = {Recent progress on gene-deleted live-attenuated African swine fever virus vaccines},
  journal = {npj Vaccines},
  year = {2024},
  volume = {9},
  number = {1},
  doi = {10.1038/s41541-024-00845-9}
}
Kostenlos starten →